Oh Canada! There is no Santa Claus to the north giving out cheap drugs to US patients
This morning HHS Secretary Alex Azar took another step toward opening the door to drugs imported from Canada. The still-developing policy initiatives pave the way to getting states to set up programs for importing less expensive drugs, as well as setting up a path for drugmakers to bring in therapies sold abroad.
With less than a year to go to the election, you could say President Donald Trump has a vested interest in cuffing the biopharma industry — as he promised from the start — before he goes back to voters selling 4 more years in the White House.